Latest Acute myeloid leukemia Stories
SEATTLE, Jan. 8, 2015 /PRNewswire/ -- CTI BioPharma Corp.
NiCord® is in clinical development as a treatment for blood cancers including leukemia and lymphoma JERUSALEM, January 6, 2015 /PRNewswire/ -- Gamida Cell [http://www.gamida-cell.com
SAN DIEGO, Dec. 22, 2014 /PRNewswire/ -- MEI Pharma, Inc.
-Significant synergy resulted with combination treatment of pacritinib and cytarabine or a MEK inhibitor- SEATTLE, Dec. 9, 2014 /PRNewswire/ -- CTI BioPharma Corp.
Company Outlines Plans for Phase III Registration Study San Diego, Dec. 8, 2014 /PRNewswire/ -- MEI Pharma, Inc.
- AbbVie Presents for the First Time Results from the Venetoclax Phase 2 Program in Acute Myelogenous Leukemia NORTH CHICAGO, Ill., Dec.
SAN FRANCISCO, Dec.
TG02 demonstrates ability to mobilize difficult-to-kill leukemic stem cells and render them vulnerable to chemotherapy. San Diego, California (PRWEB) December
-Profile Supports Potential Role in Modulating Tumor Microenvironment in Blood-Related Cancers, Including AML, MDS, CMML and CLL- SEATTLE, Dec.
SAN DIEGO and PARSIPPANY, N.J., Dec.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.